Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1159009.RAHNdebD2Vl_6O2QCpzsciXGHLiQL75ba12i5ygHpptlE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1159009.RAHNdebD2Vl_6O2QCpzsciXGHLiQL75ba12i5ygHpptlE130_assertion type Assertion NP1159009.RAHNdebD2Vl_6O2QCpzsciXGHLiQL75ba12i5ygHpptlE130_head.
- NP1159009.RAHNdebD2Vl_6O2QCpzsciXGHLiQL75ba12i5ygHpptlE130_assertion wasGeneratedBy ECO_0000203 NP1159009.RAHNdebD2Vl_6O2QCpzsciXGHLiQL75ba12i5ygHpptlE130_provenance.
- NP1159009.RAHNdebD2Vl_6O2QCpzsciXGHLiQL75ba12i5ygHpptlE130_assertion wasDerivedFrom befree-2016 NP1159009.RAHNdebD2Vl_6O2QCpzsciXGHLiQL75ba12i5ygHpptlE130_provenance.
- NP1159009.RAHNdebD2Vl_6O2QCpzsciXGHLiQL75ba12i5ygHpptlE130_assertion SIO_000772 24581742 NP1159009.RAHNdebD2Vl_6O2QCpzsciXGHLiQL75ba12i5ygHpptlE130_provenance.
- NP1159009.RAHNdebD2Vl_6O2QCpzsciXGHLiQL75ba12i5ygHpptlE130_assertion evidence source_evidence_literature NP1159009.RAHNdebD2Vl_6O2QCpzsciXGHLiQL75ba12i5ygHpptlE130_provenance.
- NP1159009.RAHNdebD2Vl_6O2QCpzsciXGHLiQL75ba12i5ygHpptlE130_assertion description "[These data provide treatment options for affected individuals and strongly suggest that investigation of GUCY1A3 and other members of the NO-sGC-cGMP pathway is warranted in both isolated early-onset achalasia and nonsyndromic moyamoya.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1159009.RAHNdebD2Vl_6O2QCpzsciXGHLiQL75ba12i5ygHpptlE130_provenance.